ArticleDiabetes, obesity & metabolism2023

Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.

Devin Abrahami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.